CA1285568C - Process for the preparation of 3,5-diamino-1,2,4-triazole derivatives - Google Patents
Process for the preparation of 3,5-diamino-1,2,4-triazole derivativesInfo
- Publication number
- CA1285568C CA1285568C CA000500565A CA500565A CA1285568C CA 1285568 C CA1285568 C CA 1285568C CA 000500565 A CA000500565 A CA 000500565A CA 500565 A CA500565 A CA 500565A CA 1285568 C CA1285568 C CA 1285568C
- Authority
- CA
- Canada
- Prior art keywords
- general formula
- compound
- process according
- stated above
- stands
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Abstract
ABSTRACT
The invention relates to a process for the preparation of 3,5-diamino-1H-1,2,4-triazole derivatives of the general Formula I
/I/
/wherein R1 and R2 each stands for hydrogen, alkyl, alkenyl, aralkyl or cycloalkyl, or R1 and R2, together with the adjacent nitrogen atom they are attached to, may form a heterocyclic ring; and R3 stands for hydrogen or alkyl/
and pharmaceutically acceptable acid addition salts thereof, which comprises a/ converting a hydroxy compound of the general Formula II
/II/
/wherein R3 is as stated above/ into a halogen compound of the general Formula III
/III/
/wherein R3 is as stated above and X stands for halogen/ and reacting the compound thus obtained with an alkali metal or alkaline earth metal salt of a phenol derivative of the general Formula IV
/IV/
/wherein R1 and R2 are as stated above/; or b/ reacting a halogen compound of the general Formula III with an alkali metal or alkaline earth metal salt of a phenol derivative of the general Formula IV
and, if desired, converting the compound of the general Formula I thus obtained into a pharmaceutically acceptable acid addition salt thereof.
The compounds of the general Formula I are derivatives having useful sustained histamine H2 blocking effect.
The advantage of the process of the present invention is that it is readily feasible on industrial scale, too, requires readily available starting materials and provides high yields.
The invention relates to a process for the preparation of 3,5-diamino-1H-1,2,4-triazole derivatives of the general Formula I
/I/
/wherein R1 and R2 each stands for hydrogen, alkyl, alkenyl, aralkyl or cycloalkyl, or R1 and R2, together with the adjacent nitrogen atom they are attached to, may form a heterocyclic ring; and R3 stands for hydrogen or alkyl/
and pharmaceutically acceptable acid addition salts thereof, which comprises a/ converting a hydroxy compound of the general Formula II
/II/
/wherein R3 is as stated above/ into a halogen compound of the general Formula III
/III/
/wherein R3 is as stated above and X stands for halogen/ and reacting the compound thus obtained with an alkali metal or alkaline earth metal salt of a phenol derivative of the general Formula IV
/IV/
/wherein R1 and R2 are as stated above/; or b/ reacting a halogen compound of the general Formula III with an alkali metal or alkaline earth metal salt of a phenol derivative of the general Formula IV
and, if desired, converting the compound of the general Formula I thus obtained into a pharmaceutically acceptable acid addition salt thereof.
The compounds of the general Formula I are derivatives having useful sustained histamine H2 blocking effect.
The advantage of the process of the present invention is that it is readily feasible on industrial scale, too, requires readily available starting materials and provides high yields.
Description
85~
PROCESS FOR THE PREPARATION OF 3,5-DIAMINO-1,2,4 -TRIAZOLF DERIVATIVES
This inventlon relates to a new and improved process for the preparation of 3,5-diamino-1,2,4-triazole deriva~ivas.
According to the present invention there is provided a process for the preparation of 3,5-diamino-1,2,4-triazole derivatives of the general Formula I
lIf and pharmaceutlcally acceptable acid addition ~alts thereo~
/wherein Rl and R2 each stands for hydrogen or a Cl-C4 alkyl; or Rl and R2, together with the adjacent nitrogen atom they are attached to form a piperldine or pyrrolidlne ring; and R3 stands for hydrogen or Cl-C4 alkyl/.
The compounds of the general Formula I are known hlstamlne H2-blockers of sustained effect. These compounds are capable of antagonizing gastric acid secretlon stimulated by histamine and are useful in antiulcus therapy.
Several procedures are known for the preparation of the compounds of the general Formula I. According to ~elgian patent ~.
:: : , No. 875,~46 an amine of the ~eneral Formula V
R1",L~
~ --NH2 lV/
/whereln Rl and R2 are as stated abovet is reacted wlth a cyanolmino derlvative of the general Eormula VI
R4 ~R5 NCN
IVl/
~ ~2135;5~;~
/wherein R~ and R5 are alkylthio or alkoxy/. The isourea or isothiourea derivative of the general Formula VII
NHJ~ R~
~2 /'~II/
thus obtained /wherein Rl and R2 are as stated above~
is treated with a substituted hydrazine of the general Formula VIII
R3--N~5--N--Z
/VIII I
/wherein R3 is as stated above and Z represents two hydrogen atoms/. In the reaction a mixture of the isomeric compounds of the general Formulae I and IX
2s R/ N ~ N'iNH
/IX/
iS~;8 is obtained /wherein Rl, R2 and R3 are as stated above/. The compound of the general Formula I is separated from the mixture by crystallization.
The serious drawback of this process is that the isomers of the general Formulae I and IX - differing from each other in the position of the R3 substituent -are formed only in the last step of the synthesis and for this reason the desired isomer of the general Formula I is obtained with large losses. Moreover the fact that the said losses occur at the very end of the lengthy synthesis, consisting of several steps, makes the process very expensive.
In order to eliminate the formation of the isomeric compounds of the general Formula IX
according to a further process described in Belgian patent No. 875,846 the isothiourea of the general Formula VII is reacted with a protected hydrazine derivative of the general Formula VIII /wherein R3 is as stated above and Z represents a protecting group/.
From the protected cyano guanidine derivative of the general Formula X
R' ~\ NCN
N~O----NJ~N~N GZ
R2/ ~ ~1 1~5~8 .
thus obtained /wherein Rl, R2, R3 and Z are as stated above/ the protecting group is removed and the cyano guanidine derivative of the general Formula XI
n/ NCN
/XI I
/wherein Rl, R2 and R3 are as stated above/
spontaneously cyclizes to the compound of the general Formula I.
According to the said Belgian patent the key intermediate of the general Formula X can also be prepared by reacting a protected hydrazine derivative of the general Formula VIII with a cyanimino derivative of the general Formula VI. The protected cyano guanidine derivative of the general Formula XII
R4~N--N=Z
NCN
/XII /
/wherein R3 and R4 are as stated above and Z stands for a protecting group/ is coupled with an amine of ~2,~55~3 the general Formula V to yield the desired intermediate of the general Formula X.
The common disadvantage of both of the above processes is the use of the protecting group Z which aims the elimination of the isomeric triazole derivative of the general Formula IX in the ring closure step of the triazole ring. It is namely known / see J.Org.Chem. 39, 1522 /1974/_7 that an analoguous reaction of dimethyl-N-cyanoimi.no-dithio carbamate and N-methyl-hydrazine leads to the formation of the isomers of the type of the general F`ormulae I and IX.
According to a further reaction disclosed in Belgian patent No. 875,846 an isothiourea derivative of the general Formula XIII
N~ ~J o--\-- NH
IXII~ I
/wherein Rl and R2 are as stated above and R8 stands for Cl 10 alkyl/ i.s treated with an amino guanidine, semicarbazicle or thiosemicarbazide of the general Formula XIV
R3--NH--NH~ NH2 / XIV~
~21355~3 /wherein Y is -NH-, oxygen or sulfur and R3 is as stated above/. The compound of the general Formula XV
J~ N'~ NH2 lXV/
/wherein Rl, R2, R3 and Y are as stated above and Q represents -NH-/ thus obtained is converted into the triazole derivative of the general Formula I by ring-closure.
According to a further procedure disclosed in the said Belgian patent an addition reaction between an isocyanate of the general Formula XVI
N~ --o~~N
/wherein Rl and R2 are as stated above and P is oxygen or sulfur/ and a compound of the general Formula XIV /wherein R3 is as stated above and Y represents -NH-/ is carried out, whereupon the ~3L2~3~S~i8 compound of the general Formula XV is cyclized into the desired triazole derivative of the general Formula I.
The common drawback of both of the above processes is that the preparation of the reactants is rather complicated, the last condensation step is very lengthy and energy consumin~ and the yields are rather moderate.
According to a further reaction described in the said Belgian patent an isothiourea of the general Formula XIII is reacted with a protected hydrazine of the general Formula VIII whereupon the protecting group is removed. The amino guanidi.ne derivative of the general Formula XVII
~--N J~ N ~ NH2 /X\~iI/ 3 /wherein Rl, R2 and ~3 are as stated above/ is reacted with carbamoyl chloride to yield the desired compound of the general Formula I.
The disadvantage of this process is that in order to eliminate the formation of the undesired isomer of the general Formula IX a protected hydrazine derivative of the general Formula VIII is used 355~8 ~wherein ~ is a protecting group/, the preparation of the reactants is complicated and the closing condensation step of the synthesis is lengthy and energy consuming.
A further reaction type disclosed in Belgian patent No. 875,846 differs from the reactions disclosed above in the fact that in the place of an amino compound of the general Formula V an acid amide of the general Formula XVIII
/ ~O~ NH2 iX\/lIIJ
/wherein Rl and R2 are as stated above/ or an acetale or cyclic acetale of the general Formula XIX
/~ NH2 /wherein R6 stands for alkyl or the /R60/2CH- group represents a cyclic acetale/ is used. The last step of the said synthesis is the formation of the group of the general Formula RlR2N-CH2- from the intermediates of the general Formulae XX and XXI
5~
N~ J~N~NH
' '' /XXt \~ ~0 ` ~ 1N~2 ~6 IXXI/
thus obtained /wherein Rl, R2, R3 and R6 are as above/
by means of known methods used in the synthesis of the compounds of the general Formula V.
According to a further method disclosed in Belgian patent No. 875,846 a key intermediate of the general Formula XXII
; ~ ~N N
X ~o ~ N J~N1 NH2 /XXII /
/wherein R3 is as stated above and X stands for halogen/ is condensed with an amine of the general Formula RlR2NH /wherein Rl and R2 are as stated above/.
According to European patent application .
~2855}~3 No. 29,303 the compounds of the general Formula I are prepared by subjecting an aldehyde of the general Formula XXIII
R~
H~J~O-- N~
O ~)(X~
/wherein R3 is as stated above/ and an amine of the general Formula RlR2NH /wherein Rl and R2 are as stated above/ to an amination reaction under reducing conditions.
According to a further reaction of the said European patent application a secondary amine of the general Formula XXIV
R2NJ~O ~ ~ ~NHz /XXIV I
/wherein R2 and R3 are as stated above/ is used as starting material which is either subjected to 551~3 reducing condensation wlth an aldehyde of the general Formula R7CH0 ~wherein the R7-CH2- group formed on reducing R7CH0 is the Rl group/ or alkylated with a compound of the general Formula R7-CH2-X /wherein .
R7-CH2- s as stated above and X stands for halogen/
to yield the desired compound of the general Formula I~
In the last four reaction types the same reaction steps are used as in the previously disclosed methods,only the order of sequence of the steps is changed. Consequently,as a matter of fact the said four procedures are accompanied by the same drawbacks as the previously discussed methods.
According to a further process disclosed in Belgian patent No. 875,846 a narrower sub-group of the compounds of the general Formula I is prepared by reacting a phenoxy alkyl derivative of the general Formula XXV
O--N~J~ NH2 .
~X,YVJ
/wherein R3 is as stated above/ with the ammonium chloride of the Formula XXVI.
1.2855~
~CH3)2N~ CH2Cl / XXVI/
T'nus a compound of the general Formula I is obtained wherein both Rl and R2 represent methyl. The disadvantage of the said process is that it is suitable for the preparation but of a narrow compound group. Moreover the preparation of the compound of the Formula XXVI and also the reaction itself is complicated and labour consuming.
According to a further process disclosed in Belgian patent No. 875,846 an amino guanidine of the general Formula XIV /wherein R3 is as stated above and Y stands for imino/ is reacted with a carbamoyl chloride of the general Formula XXVII
R~ O
\
N--C
Rg/ \Cl /XXVI~I;
/wherein R8 and Rg are suitable protecting groups/, the 3,5-diamino-lH-1,2,4-triazole derivative of the general Formula XXVIII
- : ,-:. . .~ -~N--N R
H2N J~NJ~ N
/ XXVilI /
thus obtained /wherein R3, R8 and Rg are as stated above/ is reacted with an aldehyde of the general Formula XXIX
\ ~ ~CHO
/ XXIXI
/wherein Rl and R2 are as stated above/ and the Schiff-base of the general Formula XXX
~ J~o--NJ~N~N
IXXXJ Rg /wherein Rl, R2 t R3, R8 ard R9 are as stated above/ thus obtained is reduced and finally the protecting groups are removed.
According to a modification of the said process the amino triazole of the general Formula XXVIII is reacted with an activated acid derivative of the general Formula XXXI
o R~~ ~0 ~~ o~ C~
R A
lXXX~I
/wherein Rl and R2 are as stated above and A represents halogen, hydroxy, alkoxy or acyloxy/
whereupon the acid amide of the general Formula XXXII
~\ ~ J~ (~. ;
tX~X~I/ g thus obtained /whereupon Rl, R2, R3, R8 and R9 are as stated above/ is reduced to the desired compound of the general Formula I.
According to a further modification of the ~2~ 8 above process an amino triazole of the general Formula XXVIII is reacted with an actlve ester of the general Formula XXXIII
~ 3~o~~ B
/ XXXIII /
/wherein Rl and R2 are as stated above and B is mesyloxy or toxyloxy/ to yield the desired compound of the general Formula I.
The above methods are accompanied by the disadvantages that the triazole ring is formed by the complicated methods earlier discussed and the appropriate selection and removal of the protecting groups R8 and R9 cause further problems and inconveniences.
It is the object of the present invention to overcome the above drawbacks of the known procedures and to provide an economical, readily feasible process for the preparation of the compounds of the general Formula I.
According to the present invention there is provided a process for the preparation of compounds of the general Formula I
~ 35~
~wherein Rl and R2 each stands for hydro~en or a C1-~4 alkyl; or Rl and R2 together with the ad;acent nitrogen atom they are attached to form a piperidine or pyrrolidine ring; and R3 ~tands for hydrogen or alkyl/
and pharmaceutically acceptable acid addition salts thereof which comprises a/ converting a hydroxy compound of the general formula II
HO ~--~ N~ NHz ~whereln R3 is as stated above~ lnto a halogen compound of the general Formula III
`N~ N
X ~ N NH2 ~III/
~ wherein R3 i5 as stated above and ~ stands for halogen/ and reactlng the compound thus obtalned after tranformlng it lnto a free base with an alkall metal or alkali earth metal salt of a ~8~
phenol derivative of the general Formula IV
R~
N OH
~IV/
/whereln R1 and R2 are as stated above/; or b/ reac~ing a halogen compound ol the general Formula III
after transforming lt into a free base with an alkali metal or alkali earth metal salt o~ a phenol derlvatlve of the general Formula IV
and, if desired, converting the compound of the general Formula I
thus obtained into a pharmaceutlcally acceptable acid additlon salt thereof.
The hydroxy compound of the general Formula II ls converted into the halogen derlvative of the general Formula III by method~
known per se. It is preferred to react the compound of the general Formula II with a suitable halogena~ing agent -partlcularly wlth a thlonyl halide, especially thionyl chlorlde -in an lnert solvent. The excess of thlonyl halide may preferably act as reaction medlum. As reaction medium aromatic hydrocarbons/e.g. benzene, toluene or xylene/ may also be used.
~^ .
~2~S~
The reaction may be carried out at room temperature or under heating /e.g. between 20 C and 80 C/.
The halogen derivative of the general Formula III is then reacted with an alkali metal /e.g. potassium, sodium or lithium/ or alkali earth metal /e.g. calcium or magnesium/ salt of a phenol compound of the general Formula IV. The reaction may be accomplished in a dipolar aprotic solvent /e.g.
dimethyl formamide/.
The alkali or alkali earth metal salt of the compound of the general Formula IV may be formed in the reaction mixture by reacting the phenol derivative of the general Formula IV in a dipolar aprotic solvent /e.g. dimethyl formamide/ with a hydride or alcoholate of the corresponding alkali or alkaline earth metal /e.g. sodium hydride, calcium hydride or potassium tertiary butylate/.
The compound of the general Formula I tnus obtained may be isolated by methods known per se.
The salt formation may be carried out in a known manner by reacting the compound of the general Formula I thus obtained in an organic solvent with the corresponding inorganic or organic acid /e.g.
hydrochloric acid, hydrobromic acid~ sulfuric acid, maleic acid, fumaric acid, lactic acid etc./.
The starting materials of the general Formulae II and IV are known and readily available compounds.
, . .
The compounds of the general Formula III are new, never described in prior art.
The term "alkyl" relates to straight or branched chained saturated aliphatic hydrocarbon groups having 1-5 carbon atoms /e.g. methyl, ethyl, n-propyl, isopropyl etc./. The term "alkenyl" relates to straight or branched chained olephinic hydrocarbon groups having 2-5 carbon atoms /e.g. allyl, propenyl etc./. The term "aralkyl" relates to alkyl groups substituted by an aryl radical /e.g. benzyl, ~-phenylethyl etc./. The term "cycloalkyl" relates to saturated cyclic aliphatic hydrocarbon groups having 3-8 carbon atoms /e.g. cyclobutyl, cyclopentyl, cyclohexyl etc./. The term "halogen" encompasses the fluorine, chlorine, bromine and iodine atoms and represents preferably chlorine or bromine, particularly chlorine.
The "heterocyclic group" formed by Rl and R2 and the adjacent nitrogen atom may have 5 or 6 members, may comprise one or two nitrogen, oxygen and/or sulfur atoms and may be optionally substituted.
Preferred heterocyclic groups are the pyrrolidinyl, piperidinyl, morpholinyl and piperazinyl groups.
Rl and R2 may preferably stand for methyl or together with the adjacent nitrogen atom may preferably form a pyrrolidino or piperidino group.
R3 may preferably stand for methyl.
The process of the present invention is ~2a~
particularly suitable for the preparation of l-methyl--N5- ~3-/ 3-/ /1-piperidinyl/-methyl_7-phenoxy_7--propyl} -lH-1,2,4-triazole-3,5-diamine and salts thereof.
The advantages of the process of the present invention may be summarized as follows:
a/ The process is readily feasible on industrial scale,too.
b/ No specific apparatus or equipment is required.
c/ The starting materials are readily available in large quantities,too.
d/ Since the formation of the isomeric compounds of the general Formula IX is eliminated and the synthesis of the desired compounds of the general Formula I
is carried out not stepwise but by the synthesis of two key intermediates of approximately the same size, the total yield of the synthesis is far superior to the total yields of the hitherto known methods.
Further details of the present invention are to be found in the following Examples without limiting the scope of protection to the said Examples.
Example 1 N5-/3-Chloropropyl/-lH-1,2,4-triazole-3,5--diamine hydrochloride 5 g /0,032 mole/ of N5-/3-hydroxypropyl/-lH--1,2,4-triazole-3,5-diamine are dissolved in 15 ml of benzene. To the solution 4.2 g /0,035 mole/ of thionyl chloride are added under stirring and cooling at 10 C.
The reaction mixture is slowly allowed to warm to room temperature. The reaction mixture is stirred for half an hour. The precipitated crystals are filtered off and washed with benzene. Thus 6.3 g of the desired compound are obtained, yield 92.8 %. A strongly hygroscopic white crystalline substance is obtained which liquifies on air. Mp.: 130-132 C /in a closed tube/.
Example 2 N5-/3-Chloropropyl/-lH-1~ ?, 4-triazole-3,5--diamine-hydrochloride One proceeds according to Example 1 except that no benzene is used but 10.6 ml /0,15 ml/ of thionyl chloride are applied and this excess serves as reaction medium. Thus 6.8 g of the desired compound are ob~;ained, yield 54,4 %. The product is identical with the compound prepared according to Example 1.
5S~3 Example 3 -lethyl-N5-/3-chloropropyl~-lH-1,214-triazole--diamine-hydrochloride One proceeds according to Example 2 except that 8,6 g /0.05 mole/ of 1-methyl-N5-/3-hydroxy-propyl/-l~-1,2,4-triazole-3,5-diamine are used as starting material and the reaction mixture is heated to 60 C and stirred at this temperature for 15 minutes. Thus 10.7 g of the desired compound are obtained, yield 94.7 %. Mp.: 170-172 C
/decomposition/.
Example 4 l-~ethyl-N5- {3-/ 3-/ /l-piperidinyl/-methyl 7-~_enoxy 7-propyl' -lH-1,2,4-triazole-3,5--diamine To a solution of an oily suspension of 1.0 g /0.033 mole/ of ao % sodium hydride in 20 ml of anhydrous dimethyl formamide 5.7 g /0.03 mole/ of 3-/1-piperidinylmethyl/-phenol are slowly added and the mixture is stirred for half an hour at room temperature. In a separate flask to a solution of 8.1 g /0.036 mole/ of 1-methyl-~5-/3-chloropropyl/--lH-1,2,4-triazole-3,5-diamine-hydrochloride in 15 ml of anhydrous dimethyl formamide 3.04 g /0.03 mole/ of triethyl amine are added under stirring at room temperature, the precipitated triethyl amine hydro-chloride is filtered off and washed with some ~L213~iS~3 2~ -anhydrous dimethyl formamide. The solution thus obtained is added to the dimethyl formamide solution of the phenolate prepared above under stirring at room temperature. The reaction mixture is stirred for 72 hours, at room temperature, 30 ml of water are added and it is extracted three times with 20 ml of chloroform each. The united organic phases are extracted three times with 20 ml of water each, the chlorophorm phase is dried over anhydrous magnesium sulfate and the chloroform is distilled off in vacuo. The residual brown oil /9.6 g/ becomes slowly crystalline on standing and is recrystallized from a 1:4 mixture of ethyl acetate and cyclohexane. Thus 5.6 g of the desired compound are obtained, yield 54,4 %, mp.: 93-94 C.
Example 5 l-Methyl-N5- ~3-/ 3-/ /l-piperidinyl/-methyl 7--phenoxy 7-propyl ~ -lH-1,2,4-triazole~3,5--diamine-fumarate The oily crude product prepared according to Example 4 is dissolved in 30 ml of ethanol whereupon at 50 C 3.5 g /0.03 mole/ of fumaric acid are added.
After dissolving the reaction mixture is cooled and allowed to stand in a refrigerator overnight. The precipitated crystals are filtered and washed with some ethanol. Thus 7,8 g of the desired compound are obtained, yield 56.4 %, mp.: 142-145 C.
~ZI 3~i~i6#
l-Methyl-NS- 3-/ 3-/ /l-piperidinyl/-methyl 7--phenoxy 7-propyl~ -lH-1,2,4-triazole-3,5--diamine One proceeds according to Example 4 except that 10.2 g /0.045 mole/ of l-methyl-N5-/3-chloro-propyl~-lH-1,2,4-triazole-3,5-diamine-hydrochloride are used. Thus 5.3 g of the desired compound are obtained, yield 51.4 %. The product is identical with the compound prepared according to Example 4.
Example 7 l-Methyl-N5- ~3-/ 3-/ /l-piperiqinyl/-methyl 7--Dhenoxy 7-propyl~ -lH-1,2,4-triazole-3,5--diamine One proceeds according to Example L~ except that 6.8 g /0.03 mole/ of l-methyl N5-/3-chloropropyl/--lH-1,2,4-triazole-3,5-diamine-hydrochloride are used as starting material. Thus 4.9 g of the desired compound are obtained, yield 47.6 %. The product is identical with the compound prepared according to Example 4.
Example 8 1-Methyl-N5- ~3-/ 3-/ /l-piperidinyl/-methyl 7--phenoxy 7-propyl3 -lH-1,2,4-triazole-3,5--diamine -One proceeds according to Example 4 except 3L2~35~6t~
that 1.4 g /0.033 mole/ of calcium hydride are used in the place of sodium hydride. Thus 5.1 g of the desired compound are obtained, yield 49.5 %. The product is identical with the compound prepared according to Example 4.
Example 9 l-Methyl-N5- ~3-/ 3-/ /l-pyrrolidinyl/--methyl 7-phenoxy 7-propyl~ -lH-1,2,4-triazole--3,5-diamine One proceeds according to Example 4 except that 5.3 g /0.03 mole/ of 3-/1-pyrrolidinyl-methyl/--phenol are used as starting material of the general Formula IV. Thus 4.9 g of the desired compound are 15 obtained, yield 49.4 %, mp.: 94-95 C.
Example 10 l-Methyl-N5-~ 3-/ 3-/ /l-pyrrolidinyl/-rnethyl 7--phenoxy 7-propyl~ -lH-1,2,4-triazole-3,5--diamine fumarate One proceeds according to Example 5 except that as starting material the compound prepared according to Example 9 is used. Thus 7.2 g of the desired compound are obtained, yield 53,7 %, mp.: 140-142 C.
~28~iS68 Example 11 l-Methyl-N5-{ 3-/ 3-/ /dimethylamino/_methyl 7--phenoxy 7-propyl3 -lH-1,2,4-triazole-3,5--diamine One proceeds according to Example 4 except that 4.5 g /0.03 mole/ of 3-dimethylaminomethyl--phenol are used as starting material. Thus 4.1 g of the desired compound are obtained, yield 44.9 %, m.p.: 95-96 C.
Example 12 N5- ~3-/ -/ /l-Piperidinyl/-methyl 7-phenoxy 7--propyl 3 -lH-1,2,4-triazole-3,5-diamine One proceeds according to Example 4 except 15 that 7.6 g /0.036 mole/ of N -/3-chloropropyl/-lH--1,2,4-triazole-3,5-diamine-hydrochloride are used as starting material. Thus 4.7 g of the desired compound are obtained, yield 47.4 %, mp.; 100-101 C.
Example 13 N5- {3-/ 3-/ /Dimeth~lamino/-methyl 7-Phenoxy 7--propyl 3 -lH-1,2,4-triazole-3,5-diamine One proceeds according to Example 4 except that 4.5 g /0.03 mole/ of 3-dimethylaminomethyl-phenol 25 and 7.6 g /0.036 mole/ of N5-/3-chloropropyl/-lH--1,2,4-triazole-3,5-diamine-hydrochloride are used as starting material. Thus 4.2 g of the desired compound are obtained, yield 48.2 %, mp.: 91-93 C.
PROCESS FOR THE PREPARATION OF 3,5-DIAMINO-1,2,4 -TRIAZOLF DERIVATIVES
This inventlon relates to a new and improved process for the preparation of 3,5-diamino-1,2,4-triazole deriva~ivas.
According to the present invention there is provided a process for the preparation of 3,5-diamino-1,2,4-triazole derivatives of the general Formula I
lIf and pharmaceutlcally acceptable acid addition ~alts thereo~
/wherein Rl and R2 each stands for hydrogen or a Cl-C4 alkyl; or Rl and R2, together with the adjacent nitrogen atom they are attached to form a piperldine or pyrrolidlne ring; and R3 stands for hydrogen or Cl-C4 alkyl/.
The compounds of the general Formula I are known hlstamlne H2-blockers of sustained effect. These compounds are capable of antagonizing gastric acid secretlon stimulated by histamine and are useful in antiulcus therapy.
Several procedures are known for the preparation of the compounds of the general Formula I. According to ~elgian patent ~.
:: : , No. 875,~46 an amine of the ~eneral Formula V
R1",L~
~ --NH2 lV/
/whereln Rl and R2 are as stated abovet is reacted wlth a cyanolmino derlvative of the general Eormula VI
R4 ~R5 NCN
IVl/
~ ~2135;5~;~
/wherein R~ and R5 are alkylthio or alkoxy/. The isourea or isothiourea derivative of the general Formula VII
NHJ~ R~
~2 /'~II/
thus obtained /wherein Rl and R2 are as stated above~
is treated with a substituted hydrazine of the general Formula VIII
R3--N~5--N--Z
/VIII I
/wherein R3 is as stated above and Z represents two hydrogen atoms/. In the reaction a mixture of the isomeric compounds of the general Formulae I and IX
2s R/ N ~ N'iNH
/IX/
iS~;8 is obtained /wherein Rl, R2 and R3 are as stated above/. The compound of the general Formula I is separated from the mixture by crystallization.
The serious drawback of this process is that the isomers of the general Formulae I and IX - differing from each other in the position of the R3 substituent -are formed only in the last step of the synthesis and for this reason the desired isomer of the general Formula I is obtained with large losses. Moreover the fact that the said losses occur at the very end of the lengthy synthesis, consisting of several steps, makes the process very expensive.
In order to eliminate the formation of the isomeric compounds of the general Formula IX
according to a further process described in Belgian patent No. 875,846 the isothiourea of the general Formula VII is reacted with a protected hydrazine derivative of the general Formula VIII /wherein R3 is as stated above and Z represents a protecting group/.
From the protected cyano guanidine derivative of the general Formula X
R' ~\ NCN
N~O----NJ~N~N GZ
R2/ ~ ~1 1~5~8 .
thus obtained /wherein Rl, R2, R3 and Z are as stated above/ the protecting group is removed and the cyano guanidine derivative of the general Formula XI
n/ NCN
/XI I
/wherein Rl, R2 and R3 are as stated above/
spontaneously cyclizes to the compound of the general Formula I.
According to the said Belgian patent the key intermediate of the general Formula X can also be prepared by reacting a protected hydrazine derivative of the general Formula VIII with a cyanimino derivative of the general Formula VI. The protected cyano guanidine derivative of the general Formula XII
R4~N--N=Z
NCN
/XII /
/wherein R3 and R4 are as stated above and Z stands for a protecting group/ is coupled with an amine of ~2,~55~3 the general Formula V to yield the desired intermediate of the general Formula X.
The common disadvantage of both of the above processes is the use of the protecting group Z which aims the elimination of the isomeric triazole derivative of the general Formula IX in the ring closure step of the triazole ring. It is namely known / see J.Org.Chem. 39, 1522 /1974/_7 that an analoguous reaction of dimethyl-N-cyanoimi.no-dithio carbamate and N-methyl-hydrazine leads to the formation of the isomers of the type of the general F`ormulae I and IX.
According to a further reaction disclosed in Belgian patent No. 875,846 an isothiourea derivative of the general Formula XIII
N~ ~J o--\-- NH
IXII~ I
/wherein Rl and R2 are as stated above and R8 stands for Cl 10 alkyl/ i.s treated with an amino guanidine, semicarbazicle or thiosemicarbazide of the general Formula XIV
R3--NH--NH~ NH2 / XIV~
~21355~3 /wherein Y is -NH-, oxygen or sulfur and R3 is as stated above/. The compound of the general Formula XV
J~ N'~ NH2 lXV/
/wherein Rl, R2, R3 and Y are as stated above and Q represents -NH-/ thus obtained is converted into the triazole derivative of the general Formula I by ring-closure.
According to a further procedure disclosed in the said Belgian patent an addition reaction between an isocyanate of the general Formula XVI
N~ --o~~N
/wherein Rl and R2 are as stated above and P is oxygen or sulfur/ and a compound of the general Formula XIV /wherein R3 is as stated above and Y represents -NH-/ is carried out, whereupon the ~3L2~3~S~i8 compound of the general Formula XV is cyclized into the desired triazole derivative of the general Formula I.
The common drawback of both of the above processes is that the preparation of the reactants is rather complicated, the last condensation step is very lengthy and energy consumin~ and the yields are rather moderate.
According to a further reaction described in the said Belgian patent an isothiourea of the general Formula XIII is reacted with a protected hydrazine of the general Formula VIII whereupon the protecting group is removed. The amino guanidi.ne derivative of the general Formula XVII
~--N J~ N ~ NH2 /X\~iI/ 3 /wherein Rl, R2 and ~3 are as stated above/ is reacted with carbamoyl chloride to yield the desired compound of the general Formula I.
The disadvantage of this process is that in order to eliminate the formation of the undesired isomer of the general Formula IX a protected hydrazine derivative of the general Formula VIII is used 355~8 ~wherein ~ is a protecting group/, the preparation of the reactants is complicated and the closing condensation step of the synthesis is lengthy and energy consuming.
A further reaction type disclosed in Belgian patent No. 875,846 differs from the reactions disclosed above in the fact that in the place of an amino compound of the general Formula V an acid amide of the general Formula XVIII
/ ~O~ NH2 iX\/lIIJ
/wherein Rl and R2 are as stated above/ or an acetale or cyclic acetale of the general Formula XIX
/~ NH2 /wherein R6 stands for alkyl or the /R60/2CH- group represents a cyclic acetale/ is used. The last step of the said synthesis is the formation of the group of the general Formula RlR2N-CH2- from the intermediates of the general Formulae XX and XXI
5~
N~ J~N~NH
' '' /XXt \~ ~0 ` ~ 1N~2 ~6 IXXI/
thus obtained /wherein Rl, R2, R3 and R6 are as above/
by means of known methods used in the synthesis of the compounds of the general Formula V.
According to a further method disclosed in Belgian patent No. 875,846 a key intermediate of the general Formula XXII
; ~ ~N N
X ~o ~ N J~N1 NH2 /XXII /
/wherein R3 is as stated above and X stands for halogen/ is condensed with an amine of the general Formula RlR2NH /wherein Rl and R2 are as stated above/.
According to European patent application .
~2855}~3 No. 29,303 the compounds of the general Formula I are prepared by subjecting an aldehyde of the general Formula XXIII
R~
H~J~O-- N~
O ~)(X~
/wherein R3 is as stated above/ and an amine of the general Formula RlR2NH /wherein Rl and R2 are as stated above/ to an amination reaction under reducing conditions.
According to a further reaction of the said European patent application a secondary amine of the general Formula XXIV
R2NJ~O ~ ~ ~NHz /XXIV I
/wherein R2 and R3 are as stated above/ is used as starting material which is either subjected to 551~3 reducing condensation wlth an aldehyde of the general Formula R7CH0 ~wherein the R7-CH2- group formed on reducing R7CH0 is the Rl group/ or alkylated with a compound of the general Formula R7-CH2-X /wherein .
R7-CH2- s as stated above and X stands for halogen/
to yield the desired compound of the general Formula I~
In the last four reaction types the same reaction steps are used as in the previously disclosed methods,only the order of sequence of the steps is changed. Consequently,as a matter of fact the said four procedures are accompanied by the same drawbacks as the previously discussed methods.
According to a further process disclosed in Belgian patent No. 875,846 a narrower sub-group of the compounds of the general Formula I is prepared by reacting a phenoxy alkyl derivative of the general Formula XXV
O--N~J~ NH2 .
~X,YVJ
/wherein R3 is as stated above/ with the ammonium chloride of the Formula XXVI.
1.2855~
~CH3)2N~ CH2Cl / XXVI/
T'nus a compound of the general Formula I is obtained wherein both Rl and R2 represent methyl. The disadvantage of the said process is that it is suitable for the preparation but of a narrow compound group. Moreover the preparation of the compound of the Formula XXVI and also the reaction itself is complicated and labour consuming.
According to a further process disclosed in Belgian patent No. 875,846 an amino guanidine of the general Formula XIV /wherein R3 is as stated above and Y stands for imino/ is reacted with a carbamoyl chloride of the general Formula XXVII
R~ O
\
N--C
Rg/ \Cl /XXVI~I;
/wherein R8 and Rg are suitable protecting groups/, the 3,5-diamino-lH-1,2,4-triazole derivative of the general Formula XXVIII
- : ,-:. . .~ -~N--N R
H2N J~NJ~ N
/ XXVilI /
thus obtained /wherein R3, R8 and Rg are as stated above/ is reacted with an aldehyde of the general Formula XXIX
\ ~ ~CHO
/ XXIXI
/wherein Rl and R2 are as stated above/ and the Schiff-base of the general Formula XXX
~ J~o--NJ~N~N
IXXXJ Rg /wherein Rl, R2 t R3, R8 ard R9 are as stated above/ thus obtained is reduced and finally the protecting groups are removed.
According to a modification of the said process the amino triazole of the general Formula XXVIII is reacted with an activated acid derivative of the general Formula XXXI
o R~~ ~0 ~~ o~ C~
R A
lXXX~I
/wherein Rl and R2 are as stated above and A represents halogen, hydroxy, alkoxy or acyloxy/
whereupon the acid amide of the general Formula XXXII
~\ ~ J~ (~. ;
tX~X~I/ g thus obtained /whereupon Rl, R2, R3, R8 and R9 are as stated above/ is reduced to the desired compound of the general Formula I.
According to a further modification of the ~2~ 8 above process an amino triazole of the general Formula XXVIII is reacted with an actlve ester of the general Formula XXXIII
~ 3~o~~ B
/ XXXIII /
/wherein Rl and R2 are as stated above and B is mesyloxy or toxyloxy/ to yield the desired compound of the general Formula I.
The above methods are accompanied by the disadvantages that the triazole ring is formed by the complicated methods earlier discussed and the appropriate selection and removal of the protecting groups R8 and R9 cause further problems and inconveniences.
It is the object of the present invention to overcome the above drawbacks of the known procedures and to provide an economical, readily feasible process for the preparation of the compounds of the general Formula I.
According to the present invention there is provided a process for the preparation of compounds of the general Formula I
~ 35~
~wherein Rl and R2 each stands for hydro~en or a C1-~4 alkyl; or Rl and R2 together with the ad;acent nitrogen atom they are attached to form a piperidine or pyrrolidine ring; and R3 ~tands for hydrogen or alkyl/
and pharmaceutically acceptable acid addition salts thereof which comprises a/ converting a hydroxy compound of the general formula II
HO ~--~ N~ NHz ~whereln R3 is as stated above~ lnto a halogen compound of the general Formula III
`N~ N
X ~ N NH2 ~III/
~ wherein R3 i5 as stated above and ~ stands for halogen/ and reactlng the compound thus obtalned after tranformlng it lnto a free base with an alkall metal or alkali earth metal salt of a ~8~
phenol derivative of the general Formula IV
R~
N OH
~IV/
/whereln R1 and R2 are as stated above/; or b/ reac~ing a halogen compound ol the general Formula III
after transforming lt into a free base with an alkali metal or alkali earth metal salt o~ a phenol derlvatlve of the general Formula IV
and, if desired, converting the compound of the general Formula I
thus obtained into a pharmaceutlcally acceptable acid additlon salt thereof.
The hydroxy compound of the general Formula II ls converted into the halogen derlvative of the general Formula III by method~
known per se. It is preferred to react the compound of the general Formula II with a suitable halogena~ing agent -partlcularly wlth a thlonyl halide, especially thionyl chlorlde -in an lnert solvent. The excess of thlonyl halide may preferably act as reaction medlum. As reaction medium aromatic hydrocarbons/e.g. benzene, toluene or xylene/ may also be used.
~^ .
~2~S~
The reaction may be carried out at room temperature or under heating /e.g. between 20 C and 80 C/.
The halogen derivative of the general Formula III is then reacted with an alkali metal /e.g. potassium, sodium or lithium/ or alkali earth metal /e.g. calcium or magnesium/ salt of a phenol compound of the general Formula IV. The reaction may be accomplished in a dipolar aprotic solvent /e.g.
dimethyl formamide/.
The alkali or alkali earth metal salt of the compound of the general Formula IV may be formed in the reaction mixture by reacting the phenol derivative of the general Formula IV in a dipolar aprotic solvent /e.g. dimethyl formamide/ with a hydride or alcoholate of the corresponding alkali or alkaline earth metal /e.g. sodium hydride, calcium hydride or potassium tertiary butylate/.
The compound of the general Formula I tnus obtained may be isolated by methods known per se.
The salt formation may be carried out in a known manner by reacting the compound of the general Formula I thus obtained in an organic solvent with the corresponding inorganic or organic acid /e.g.
hydrochloric acid, hydrobromic acid~ sulfuric acid, maleic acid, fumaric acid, lactic acid etc./.
The starting materials of the general Formulae II and IV are known and readily available compounds.
, . .
The compounds of the general Formula III are new, never described in prior art.
The term "alkyl" relates to straight or branched chained saturated aliphatic hydrocarbon groups having 1-5 carbon atoms /e.g. methyl, ethyl, n-propyl, isopropyl etc./. The term "alkenyl" relates to straight or branched chained olephinic hydrocarbon groups having 2-5 carbon atoms /e.g. allyl, propenyl etc./. The term "aralkyl" relates to alkyl groups substituted by an aryl radical /e.g. benzyl, ~-phenylethyl etc./. The term "cycloalkyl" relates to saturated cyclic aliphatic hydrocarbon groups having 3-8 carbon atoms /e.g. cyclobutyl, cyclopentyl, cyclohexyl etc./. The term "halogen" encompasses the fluorine, chlorine, bromine and iodine atoms and represents preferably chlorine or bromine, particularly chlorine.
The "heterocyclic group" formed by Rl and R2 and the adjacent nitrogen atom may have 5 or 6 members, may comprise one or two nitrogen, oxygen and/or sulfur atoms and may be optionally substituted.
Preferred heterocyclic groups are the pyrrolidinyl, piperidinyl, morpholinyl and piperazinyl groups.
Rl and R2 may preferably stand for methyl or together with the adjacent nitrogen atom may preferably form a pyrrolidino or piperidino group.
R3 may preferably stand for methyl.
The process of the present invention is ~2a~
particularly suitable for the preparation of l-methyl--N5- ~3-/ 3-/ /1-piperidinyl/-methyl_7-phenoxy_7--propyl} -lH-1,2,4-triazole-3,5-diamine and salts thereof.
The advantages of the process of the present invention may be summarized as follows:
a/ The process is readily feasible on industrial scale,too.
b/ No specific apparatus or equipment is required.
c/ The starting materials are readily available in large quantities,too.
d/ Since the formation of the isomeric compounds of the general Formula IX is eliminated and the synthesis of the desired compounds of the general Formula I
is carried out not stepwise but by the synthesis of two key intermediates of approximately the same size, the total yield of the synthesis is far superior to the total yields of the hitherto known methods.
Further details of the present invention are to be found in the following Examples without limiting the scope of protection to the said Examples.
Example 1 N5-/3-Chloropropyl/-lH-1,2,4-triazole-3,5--diamine hydrochloride 5 g /0,032 mole/ of N5-/3-hydroxypropyl/-lH--1,2,4-triazole-3,5-diamine are dissolved in 15 ml of benzene. To the solution 4.2 g /0,035 mole/ of thionyl chloride are added under stirring and cooling at 10 C.
The reaction mixture is slowly allowed to warm to room temperature. The reaction mixture is stirred for half an hour. The precipitated crystals are filtered off and washed with benzene. Thus 6.3 g of the desired compound are obtained, yield 92.8 %. A strongly hygroscopic white crystalline substance is obtained which liquifies on air. Mp.: 130-132 C /in a closed tube/.
Example 2 N5-/3-Chloropropyl/-lH-1~ ?, 4-triazole-3,5--diamine-hydrochloride One proceeds according to Example 1 except that no benzene is used but 10.6 ml /0,15 ml/ of thionyl chloride are applied and this excess serves as reaction medium. Thus 6.8 g of the desired compound are ob~;ained, yield 54,4 %. The product is identical with the compound prepared according to Example 1.
5S~3 Example 3 -lethyl-N5-/3-chloropropyl~-lH-1,214-triazole--diamine-hydrochloride One proceeds according to Example 2 except that 8,6 g /0.05 mole/ of 1-methyl-N5-/3-hydroxy-propyl/-l~-1,2,4-triazole-3,5-diamine are used as starting material and the reaction mixture is heated to 60 C and stirred at this temperature for 15 minutes. Thus 10.7 g of the desired compound are obtained, yield 94.7 %. Mp.: 170-172 C
/decomposition/.
Example 4 l-~ethyl-N5- {3-/ 3-/ /l-piperidinyl/-methyl 7-~_enoxy 7-propyl' -lH-1,2,4-triazole-3,5--diamine To a solution of an oily suspension of 1.0 g /0.033 mole/ of ao % sodium hydride in 20 ml of anhydrous dimethyl formamide 5.7 g /0.03 mole/ of 3-/1-piperidinylmethyl/-phenol are slowly added and the mixture is stirred for half an hour at room temperature. In a separate flask to a solution of 8.1 g /0.036 mole/ of 1-methyl-~5-/3-chloropropyl/--lH-1,2,4-triazole-3,5-diamine-hydrochloride in 15 ml of anhydrous dimethyl formamide 3.04 g /0.03 mole/ of triethyl amine are added under stirring at room temperature, the precipitated triethyl amine hydro-chloride is filtered off and washed with some ~L213~iS~3 2~ -anhydrous dimethyl formamide. The solution thus obtained is added to the dimethyl formamide solution of the phenolate prepared above under stirring at room temperature. The reaction mixture is stirred for 72 hours, at room temperature, 30 ml of water are added and it is extracted three times with 20 ml of chloroform each. The united organic phases are extracted three times with 20 ml of water each, the chlorophorm phase is dried over anhydrous magnesium sulfate and the chloroform is distilled off in vacuo. The residual brown oil /9.6 g/ becomes slowly crystalline on standing and is recrystallized from a 1:4 mixture of ethyl acetate and cyclohexane. Thus 5.6 g of the desired compound are obtained, yield 54,4 %, mp.: 93-94 C.
Example 5 l-Methyl-N5- ~3-/ 3-/ /l-piperidinyl/-methyl 7--phenoxy 7-propyl ~ -lH-1,2,4-triazole~3,5--diamine-fumarate The oily crude product prepared according to Example 4 is dissolved in 30 ml of ethanol whereupon at 50 C 3.5 g /0.03 mole/ of fumaric acid are added.
After dissolving the reaction mixture is cooled and allowed to stand in a refrigerator overnight. The precipitated crystals are filtered and washed with some ethanol. Thus 7,8 g of the desired compound are obtained, yield 56.4 %, mp.: 142-145 C.
~ZI 3~i~i6#
l-Methyl-NS- 3-/ 3-/ /l-piperidinyl/-methyl 7--phenoxy 7-propyl~ -lH-1,2,4-triazole-3,5--diamine One proceeds according to Example 4 except that 10.2 g /0.045 mole/ of l-methyl-N5-/3-chloro-propyl~-lH-1,2,4-triazole-3,5-diamine-hydrochloride are used. Thus 5.3 g of the desired compound are obtained, yield 51.4 %. The product is identical with the compound prepared according to Example 4.
Example 7 l-Methyl-N5- ~3-/ 3-/ /l-piperiqinyl/-methyl 7--Dhenoxy 7-propyl~ -lH-1,2,4-triazole-3,5--diamine One proceeds according to Example L~ except that 6.8 g /0.03 mole/ of l-methyl N5-/3-chloropropyl/--lH-1,2,4-triazole-3,5-diamine-hydrochloride are used as starting material. Thus 4.9 g of the desired compound are obtained, yield 47.6 %. The product is identical with the compound prepared according to Example 4.
Example 8 1-Methyl-N5- ~3-/ 3-/ /l-piperidinyl/-methyl 7--phenoxy 7-propyl3 -lH-1,2,4-triazole-3,5--diamine -One proceeds according to Example 4 except 3L2~35~6t~
that 1.4 g /0.033 mole/ of calcium hydride are used in the place of sodium hydride. Thus 5.1 g of the desired compound are obtained, yield 49.5 %. The product is identical with the compound prepared according to Example 4.
Example 9 l-Methyl-N5- ~3-/ 3-/ /l-pyrrolidinyl/--methyl 7-phenoxy 7-propyl~ -lH-1,2,4-triazole--3,5-diamine One proceeds according to Example 4 except that 5.3 g /0.03 mole/ of 3-/1-pyrrolidinyl-methyl/--phenol are used as starting material of the general Formula IV. Thus 4.9 g of the desired compound are 15 obtained, yield 49.4 %, mp.: 94-95 C.
Example 10 l-Methyl-N5-~ 3-/ 3-/ /l-pyrrolidinyl/-rnethyl 7--phenoxy 7-propyl~ -lH-1,2,4-triazole-3,5--diamine fumarate One proceeds according to Example 5 except that as starting material the compound prepared according to Example 9 is used. Thus 7.2 g of the desired compound are obtained, yield 53,7 %, mp.: 140-142 C.
~28~iS68 Example 11 l-Methyl-N5-{ 3-/ 3-/ /dimethylamino/_methyl 7--phenoxy 7-propyl3 -lH-1,2,4-triazole-3,5--diamine One proceeds according to Example 4 except that 4.5 g /0.03 mole/ of 3-dimethylaminomethyl--phenol are used as starting material. Thus 4.1 g of the desired compound are obtained, yield 44.9 %, m.p.: 95-96 C.
Example 12 N5- ~3-/ -/ /l-Piperidinyl/-methyl 7-phenoxy 7--propyl 3 -lH-1,2,4-triazole-3,5-diamine One proceeds according to Example 4 except 15 that 7.6 g /0.036 mole/ of N -/3-chloropropyl/-lH--1,2,4-triazole-3,5-diamine-hydrochloride are used as starting material. Thus 4.7 g of the desired compound are obtained, yield 47.4 %, mp.; 100-101 C.
Example 13 N5- {3-/ 3-/ /Dimeth~lamino/-methyl 7-Phenoxy 7--propyl 3 -lH-1,2,4-triazole-3,5-diamine One proceeds according to Example 4 except that 4.5 g /0.03 mole/ of 3-dimethylaminomethyl-phenol 25 and 7.6 g /0.036 mole/ of N5-/3-chloropropyl/-lH--1,2,4-triazole-3,5-diamine-hydrochloride are used as starting material. Thus 4.2 g of the desired compound are obtained, yield 48.2 %, mp.: 91-93 C.
Claims (12)
1. A process for the preparation of 3,5-diamino-1H-1,2,4-triazole derivatives of the general Formula I
/I/
/wherein R1 and R2 each stands for hydrogen or a C1-C4 alkyl or R1 and R2, together with the adjacent nitrogen atom they are attached to form a piperidine or pyrrolidine ring; and R3 stands for hydrogen or a C1-C4 alkyl/, and pharmaceutically acceptable acid addition salts thereof, which comprises a/ converting a hydroxy compound of the general Formula II
/II/
/wherein R3 is as stated above/ into a halogen compound of the general Formula III
/III/
/wherein R3 is as stated above and X stands for halogen/ and reacting the compound thus obtained after transforming it into a free base with an alkali metal or alkaline earth metal salt of a phenol derivative of the general Formula IV
/IV/
wherein R1 and R2 are as stated above; or b. reacting a halogeno compound of the general Formula III
after transforming it into a free base with an alkali metal or alkaline earth metal salt of a phenol derivative of the general Formula IV
and, if desired, converting the compound of the general Formula I
thus obtained into a pharmaceutically acceptable acid addition salt thereof.
/I/
/wherein R1 and R2 each stands for hydrogen or a C1-C4 alkyl or R1 and R2, together with the adjacent nitrogen atom they are attached to form a piperidine or pyrrolidine ring; and R3 stands for hydrogen or a C1-C4 alkyl/, and pharmaceutically acceptable acid addition salts thereof, which comprises a/ converting a hydroxy compound of the general Formula II
/II/
/wherein R3 is as stated above/ into a halogen compound of the general Formula III
/III/
/wherein R3 is as stated above and X stands for halogen/ and reacting the compound thus obtained after transforming it into a free base with an alkali metal or alkaline earth metal salt of a phenol derivative of the general Formula IV
/IV/
wherein R1 and R2 are as stated above; or b. reacting a halogeno compound of the general Formula III
after transforming it into a free base with an alkali metal or alkaline earth metal salt of a phenol derivative of the general Formula IV
and, if desired, converting the compound of the general Formula I
thus obtained into a pharmaceutically acceptable acid addition salt thereof.
2. A process according to claim 1, which comprises reacting a compound of the general Formula II with a thionyl halide.
3. A process according to claim 1, which comprises reacting a compound of the general Formula II with a thionyl chloride.
4. A process according to claim 2, which comprises carrying out the reaction in an excess of thionyl halide or in an inert organic solvent.
5. A process according to claim 4, wherein an aromatic hydrocarbon is used as solvent.
6. A process according to claim 4, wherein toluene, benzene or zylene is used as solvent.
7. A process according to claim 1, wherein there is used a sodium, potassium, calcium or magnesium, salt of a compound of the general Formula IV.
8. A process according to claim 1 or 7, wherein the alkali or alkaline earth metal salt of the compound of the general Formula IV is prepared in the reaction mixture.
9. A process according to claim 7 wherein the reaction is is carried out in an inert dipolar aprotic organic solvent.
10. A process according to claim 9, which comprises using dimethyl formamide as solvent.
11. A process according to claim 1 for the preparation of 1-methyl-N5-{3-[3-[/1-piperidinyl/-methyl]-phenoxy]-propyl}-1H-1,2,4-triazole-3,5-diamine and pharmaceutically acceptable acid addition salts thereof, which comprises using as starting material compounds of the general Formula II and IV, in which R1 and R2 together with the adjacent nitrogen atom, they are attached to form a piperidino ring and R3 represents methyl.
12. A process according to claim 11 wherein thionyl chloride is used as the halogenating agent.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU315/85 | 1985-01-29 | ||
| HU85315A HU193253B (en) | 1985-01-29 | 1985-01-29 | Process for preparing 3,5-diamino-1,2,4-triazole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1285568C true CA1285568C (en) | 1991-07-02 |
Family
ID=10949054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000500565A Expired - Lifetime CA1285568C (en) | 1985-01-29 | 1986-01-29 | Process for the preparation of 3,5-diamino-1,2,4-triazole derivatives |
Country Status (18)
| Country | Link |
|---|---|
| JP (1) | JPS61176576A (en) |
| CN (1) | CN1015456B (en) |
| AR (1) | AR240046A1 (en) |
| AT (1) | AT395149B (en) |
| CA (1) | CA1285568C (en) |
| CS (1) | CS253739B2 (en) |
| DD (1) | DD242807A5 (en) |
| DE (1) | DE3602648A1 (en) |
| DK (1) | DK42986A (en) |
| ES (1) | ES8704910A1 (en) |
| FI (1) | FI860432A (en) |
| GB (1) | GB2170805B (en) |
| HU (1) | HU193253B (en) |
| IT (1) | IT1190608B (en) |
| NO (1) | NO167091C (en) |
| PL (1) | PL146491B1 (en) |
| PT (1) | PT81935B (en) |
| SE (1) | SE8600385L (en) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2023133B (en) * | 1978-04-26 | 1982-09-08 | Glaxo Group Ltd | Heterocyclic derivatives |
| AU539189B2 (en) * | 1979-10-22 | 1984-09-13 | Glaxo Group Limited | 1h-1,2,4-triazole derivatives |
| DK558181A (en) * | 1981-01-30 | 1982-07-31 | Smithkline Corp | METHOD OF PREPARING 3,5-DIAMINO-1,2,4-TRIAZOLES |
| DE3336410A1 (en) * | 1983-10-06 | 1985-04-18 | Ludwig Heumann & Co GmbH, 8500 Nürnberg | SULFEN AMIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS |
| DE3341750A1 (en) * | 1983-11-18 | 1985-05-30 | Ludwig Heumann & Co GmbH, 8500 Nürnberg | 1,2,4-Triazole derivatives, process for their preparation and medicaments containing these compounds |
-
1985
- 1985-01-29 HU HU85315A patent/HU193253B/en unknown
-
1986
- 1986-01-19 IT IT19218/86A patent/IT1190608B/en active
- 1986-01-27 CS CS86576A patent/CS253739B2/en unknown
- 1986-01-29 CA CA000500565A patent/CA1285568C/en not_active Expired - Lifetime
- 1986-01-29 DD DD86286590A patent/DD242807A5/en not_active IP Right Cessation
- 1986-01-29 JP JP61017700A patent/JPS61176576A/en active Granted
- 1986-01-29 AR AR302989A patent/AR240046A1/en active
- 1986-01-29 CN CN86100724A patent/CN1015456B/en not_active Expired
- 1986-01-29 AT AT0021086A patent/AT395149B/en not_active IP Right Cessation
- 1986-01-29 NO NO860324A patent/NO167091C/en unknown
- 1986-01-29 DK DK42986A patent/DK42986A/en not_active Application Discontinuation
- 1986-01-29 ES ES551388A patent/ES8704910A1/en not_active Expired
- 1986-01-29 SE SE8600385A patent/SE8600385L/en not_active Application Discontinuation
- 1986-01-29 GB GB08602136A patent/GB2170805B/en not_active Expired
- 1986-01-29 PT PT81935A patent/PT81935B/en not_active IP Right Cessation
- 1986-01-29 DE DE19863602648 patent/DE3602648A1/en active Granted
- 1986-01-29 PL PL1986257689A patent/PL146491B1/en unknown
- 1986-01-29 FI FI860432A patent/FI860432A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FI860432A0 (en) | 1986-01-29 |
| DK42986A (en) | 1986-07-30 |
| ATA21086A (en) | 1992-02-15 |
| AR240046A1 (en) | 1990-01-31 |
| CN86100724A (en) | 1986-08-13 |
| NO860324L (en) | 1986-07-30 |
| NO167091B (en) | 1991-06-24 |
| DD242807A5 (en) | 1987-02-11 |
| GB2170805B (en) | 1988-04-27 |
| JPH0524906B2 (en) | 1993-04-09 |
| SE8600385L (en) | 1986-07-30 |
| GB8602136D0 (en) | 1986-03-05 |
| PL257689A1 (en) | 1987-02-09 |
| DK42986D0 (en) | 1986-01-29 |
| IT8619218A0 (en) | 1986-01-19 |
| CN1015456B (en) | 1992-02-12 |
| JPS61176576A (en) | 1986-08-08 |
| CS253739B2 (en) | 1987-12-17 |
| IT1190608B (en) | 1988-02-16 |
| PT81935B (en) | 1987-11-30 |
| GB2170805A (en) | 1986-08-13 |
| FI860432A (en) | 1986-07-30 |
| SE8600385D0 (en) | 1986-01-29 |
| PT81935A (en) | 1986-02-01 |
| DE3602648A1 (en) | 1986-09-11 |
| AT395149B (en) | 1992-09-25 |
| PL146491B1 (en) | 1989-02-28 |
| DE3602648C2 (en) | 1990-09-06 |
| HUT40632A (en) | 1987-01-28 |
| HU193253B (en) | 1987-08-28 |
| ES8704910A1 (en) | 1987-04-16 |
| ES551388A0 (en) | 1987-04-16 |
| NO167091C (en) | 1991-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2054544A1 (en) | Process for the preparation of piperazine derivatives | |
| JPH04270257A (en) | N-alkylation of ureas | |
| CA2175246C (en) | Process for preparing 1-amino-1,2,3-triazole | |
| Lkizler et al. | A convenient synthesis of 4‐amino‐3, 5‐dialkyl‐4H‐1, 2, 4‐triazoles | |
| CZ20014657A3 (en) | Process for preparing substituted cyclopentane derivatives and their novel crystal structures | |
| CA1100959A (en) | Indolo (2,3-a) quinolizidines, preparation and therapeutic use | |
| PL187896B1 (en) | Method of obtaining derivatives of quanidine, their intermediate compounds and method of obtaining them | |
| CA1285568C (en) | Process for the preparation of 3,5-diamino-1,2,4-triazole derivatives | |
| US6180787B1 (en) | Process for preparing o-(3-amino-2-hydroxy-propyl)-hydroxymic acid halides | |
| EP0301549B1 (en) | 1-[2-(Phenylmethyl)phenyl]-piperazine compounds, a process for preparing them and pharmaceutical compostions containing them | |
| US6794543B2 (en) | Method for producing arylpoly(oxalkyl)-benzyldimethyl-ammonium derivatives | |
| US4062891A (en) | N-formyl-2,3,5,6-dibenzobicyclo[5.1.0]octan-4-methylamine | |
| EP0294615B1 (en) | Cyclobutene-3,4-dione-intermediates and their use in the preparation of histamine h2-antagonists | |
| CA1225101A (en) | Bevantolol preparation | |
| CA1130305A (en) | Process for the preparation of n,n'-disubstituted 2-naphthaleneethanimidamide and intermediates used therein | |
| CA1054601A (en) | Process for the production of 1-amino-3-phenyl indoles derivatives having antimicrobial and antidepressant properties | |
| EP0655436A1 (en) | Improved process for the manufacture of cycloalkyl and haloalkyl o-aminophenyl ketones | |
| US5939548A (en) | Process for preparation of 3-piperazinylbenzisothiazoles | |
| CA1242200A (en) | N-nitroso compounds, and their preparation and use | |
| US4977274A (en) | 4-hydroxyindole derivatives, the process for preparation thereof and their use | |
| US4189444A (en) | Process for the preparation of N,N'-disubstituted 2-naphthaleneethanimidamide and intermediates used therein | |
| SE469894B (en) | Intermediates for Preparation of 5-Ethyl-4- (2-Phenoxyethyl) - 2H-1,2,4-Triazole-3 (4H) -one and Process for their Preparation | |
| EP0131921A2 (en) | Ortho-(mono-substituted amino)phenylimines and production thereof | |
| CA2030076C (en) | 2-aromatic-3-halobenzothiazepines | |
| Shafiee et al. | Syntheses of substituted‐1, 2, 4‐triazoles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKLA | Lapsed |